Publications

Aptahem participates in scientific conferences that are relevant for research areas such as intensive care, haematology and others related to the syndrome sepsis.

• Publication in British Journal of Pharmacology on 9 December 2024: “Antithrombotic but not anticoagulant activity of the thrombin-binding RNA aptamer Apta-1”
• Publication in Cells, published on 28 February 2024: “Therapeutic Effects of a Novel Aptamer on Coronaviral Infection-Induced Lung Injury and Systemic Inflammatory Responses”
• Poster presented at the conference International Society on Thrombosis and Haemostasis (ISTH) 24-28 June 2023: “The RNA aptamer, Apta-1 targeting evolutionarily conserved motif on thrombin cures endotoxemia and reduces thrombosis in animal models by inhibiting aggregation and secretion of platelets“
• Poster presented at the conference Intensive Care & Emergency Medicine (ISICEM) 24-27 March 2020:
  “A Novel Protein-binding RNA Aptamer, Apta-1, Emerges as a New Therapeutic Tool to Combat Sepsis“
• Article in Nature Biopharma Dealmakers, June 2018:
  “Mining parasite evolution to create inflammatory disease drugs“